- Home
- APRE vs PAVM Comparison
APRE vs PAVM Comparison
Compare APRE & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- PAVM
- Stock Information
- Founded
- APRE 2006
- PAVM 2014
- Country
- APRE United States
- PAVM United States
- Employees
- APRE N/A
- PAVM N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- PAVM Medical/Dental Instruments
- Sector
- APRE Health Care
- PAVM Health Care
- Exchange
- APRE Nasdaq
- PAVM Nasdaq
- Market Cap
- APRE 8.3M
- PAVM 9.7M
- IPO Year
- APRE 2019
- PAVM 2016
- Fundamental
- Price
- APRE $1.47
- PAVM $0.49
- Analyst Decision
- APRE Strong Buy
- PAVM Strong Buy
- Analyst Count
- APRE 1
- PAVM 1
- Target Price
- APRE $20.00
- PAVM $20.00
- AVG Volume (30 Days)
- APRE 40.4K
- PAVM 223.3K
- Earning Date
- APRE 11-06-2025
- PAVM 11-12-2025
- Dividend Yield
- APRE N/A
- PAVM N/A
- EPS Growth
- APRE N/A
- PAVM N/A
- EPS
- APRE N/A
- PAVM 0.83
- Revenue
- APRE $841,012.00
- PAVM $1,020,000.00
- Revenue This Year
- APRE N/A
- PAVM N/A
- Revenue Next Year
- APRE N/A
- PAVM $234.47
- P/E Ratio
- APRE N/A
- PAVM $0.58
- Revenue Growth
- APRE N/A
- PAVM N/A
- 52 Week Low
- APRE $1.37
- PAVM $0.30
- 52 Week High
- APRE $5.01
- PAVM $1.29
- Technical
- Relative Strength Index (RSI)
- APRE 45.12
- PAVM 63.59
- Support Level
- APRE $1.46
- PAVM $0.44
- Resistance Level
- APRE $1.57
- PAVM $0.47
- Average True Range (ATR)
- APRE 0.08
- PAVM 0.03
- MACD
- APRE 0.01
- PAVM 0.01
- Stochastic Oscillator
- APRE 54.45
- PAVM 71.59
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.